COVID-19

spot_img

India’s Covid-19 Cases Continue to Decline with 9,355 New Infections

India has seen a further decline in its daily Covid-19 cases as it logged 9,355 new infections, according to the Union Health Ministry's data. The country's active cases have also decreased from 61,013 to 57,410. The daily positivity rate has been recorded at 5.38 per cent, with a weekly positivity rate of 5.61 per cent. The total Covid case tally in India has now...

COVAXIN production to be demand-driven, says Bharat Biotech

Bharat Biotech, the Hyderabad-based vaccine maker of COVAXIN, announced that it will wait and assess the demand before resuming the production of the indigenously developed COVID-19 vaccine. The move comes as India sees a resurgence of COVID-19 cases in various parts of the country. "Covaxin is available for supplies based on demand," Bharat Biotech stated. The company had earlier stopped the production of Covaxin in...

iNCOVACC: Bharat Biotech Reveals World’s 1st Nasal COVID Vaccine Price

Bharat Biotech, a global leader in vaccine innovation and developer of vaccines for infectious diseases has dedicated iNCOVACC® (BBV154) to the nation, world’s 1st COVID intranasal vaccine for Primary series and Heterologous booster. iNCOVACC® is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein. This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results. Product development and...

Assessing India’s Readiness to Combat New Covid Variant BF.7

India Sees a gradual rise in Covid Cases Due to a new Covid Variant BF.7. The current wave of Covid cases in India has been attributed to the Omicron sub-variant, BF.7. According to virology logic, BF.7 should be more infectious than Omicron but less fatal. This follows the pattern of viruses adapting and mutating over time to become more transmissible and less lethal in...

Bharat Biotech iNCOVACC Vaccine priced ₹800 in CoWIN, ₹325 for the Govt Supplies, Rollout in January 2023

Hyderabad, Dec 27, 2022: Bharat Biotech iNCOVACC® (BBV154),the nasal vaccine for covid-19 is scheduled to be introduced in the country as a booster dose shortly. iNCOVACC® is now available on CoWin, and priced at INR 800 for private markets and priced at INR 325 for supplies to Govt of India and State Governments. The price is exclusive of GST. Earlier this month, Bharat Biotech received...

Bharat Biotech Nasal Vaccine as Covid Booster Dose, First in Hospitals: Govt

Indians' will soon have access to Bharat Biotech's covid-19 nasal vaccine "iNCOVACC" . Health Minister Dr Mansukh Mandaviya said that Bharat biotech nasal vaccine has been approved and will soon be added in CoWIN app. The Covid-19 vaccine has received the approval for use as a booster dose -Dr Mansukh Mandaviya said. Bharat Biotech's intranasal Covid vaccine will be available in private centres and will...

India increases surveillance as more coronavirus news breaks in China

Coronavirus News: Covid is Not Over Yet - warns the Indian Health Minister. His statement came in response to the increasing number of Covid-19 cases in China, Union Health Minister Mansukh Mandaviya stated that he had reviewed the country's coronavirus situation with experts and officials, added that Covid-19 was still present, and instructed all relevant officials to remain vigilant and to step up surveillance. "In...

iNCOVACC Fast Facts: World’s first Intranasal vaccine approved by India

Bharat Biotech iNCOVACC®️ (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation for ages 18 and above, in India, for heterologous booster doses. In heterologous boosting, a person administered a different vaccine from the one that was used for the primary dose series. Key Facts about iNCOVACC Vaccine iNCOVACC®️ is the world’s first Intranasal vaccine for COVID to...

Nations are destroying Millions of Moderna Covid19 Vaccines

9 million doses of Moderna will be disposed of in Switzerland (MRNA.O) The government announced  that 5.1 million doses of COVID-19 vaccine that have passed their expiration date will follow suit by February. The wastage is a result of Switzerland's decision to acquire more vaccines than was necessary to ensure that its population of 8.7 million people would have access to enough doses even...

Good News: Canada’s New Covid jab rule for Int’l travelers from Oct 1

Here is a good news for international travelers travelling to Canada. Canada stated has revised its visitor entry rules, and announced that visitors from outside Canada will no longer need the Covid-19 vaccination in order to enter the land of maple syrup. The removal of border measures has been facilitated by a number of factors, including modelling that indicates that Canada has largely passed the...

Latest Updates